Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24918 | 297 | 41.3 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
183 | 3 | APTAMER//G QUADRUPLEX//RIBOZYME | 56307 |
389 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//OLIGONUCLEOTIDES//PEPTIDE NUCLEIC ACID | 16949 |
24918 | 1 | TRANSCRIPTION FACTOR DECOY//DECOY//NF KAPPA B DECOY | 297 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR DECOY | authKW | 1060417 | 6% | 54% | 19 |
2 | DECOY | authKW | 914188 | 11% | 26% | 34 |
3 | NF KAPPA B DECOY | authKW | 541108 | 3% | 53% | 10 |
4 | CLIN GENE THER Y MED | address | 308437 | 1% | 100% | 3 |
5 | TRANSCRIPTION FACTOR DECOY TFD | authKW | 308437 | 1% | 100% | 3 |
6 | PNA DNA CHIMERAS | authKW | 246742 | 2% | 40% | 6 |
7 | GENE THER Y SCI | address | 237488 | 10% | 8% | 29 |
8 | CRYBP1 | authKW | 205624 | 1% | 100% | 2 |
9 | SYNTHETIC DOUBLE STRANDED OLIGODEOXYNUCLEOTIDE | authKW | 205624 | 1% | 100% | 2 |
10 | CLIN GENE THER Y | address | 198211 | 7% | 9% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 573 | 17% | 0% | 51 |
2 | Biochemistry & Molecular Biology | 359 | 31% | 0% | 93 |
3 | Biotechnology & Applied Microbiology | 250 | 13% | 0% | 40 |
4 | Peripheral Vascular Diseases | 208 | 8% | 0% | 25 |
5 | Genetics & Heredity | 168 | 11% | 0% | 33 |
6 | Cardiac & Cardiovascular System | 154 | 10% | 0% | 30 |
7 | Pharmacology & Pharmacy | 108 | 13% | 0% | 40 |
8 | Cell Biology | 90 | 11% | 0% | 32 |
9 | Biophysics | 82 | 7% | 0% | 21 |
10 | Chemistry, Medicinal | 73 | 5% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN GENE THER Y MED | 308437 | 1% | 100% | 3 |
2 | GENE THER Y SCI | 237488 | 10% | 8% | 29 |
3 | CLIN GENE THER Y | 198211 | 7% | 9% | 22 |
4 | ER GENTECH | 197700 | 3% | 19% | 10 |
5 | KOREAN MINIST SCI TECHNOL | 115660 | 1% | 38% | 3 |
6 | BIOL MOL CELLULARIE CANC | 102812 | 0% | 100% | 1 |
7 | BRINDAVAN | 102812 | 0% | 100% | 1 |
8 | DEV PHARMACOL PHARMACOGEN TREATMENT THALASS | 102812 | 0% | 100% | 1 |
9 | DEV PHARMACOL PHARMACOGENOM TREATMENT THALA | 102812 | 0% | 100% | 1 |
10 | DIPARTIMENTO BIOMED TER IE AVANZATE | 102812 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENE THERAPY | 5896 | 5% | 0% | 15 |
2 | JOURNAL OF GENE MEDICINE | 3574 | 2% | 0% | 7 |
3 | CURRENT DRUG TARGETS | 2750 | 2% | 0% | 7 |
4 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 1876 | 1% | 0% | 4 |
5 | MINERVA BIOTECNOLOGICA | 1733 | 1% | 1% | 3 |
6 | CURRENT GENE THERAPY | 746 | 1% | 0% | 2 |
7 | EXPERIMENTAL NEPHROLOGY | 742 | 1% | 0% | 2 |
8 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | 434 | 0% | 0% | 1 |
9 | CIRCULATION RESEARCH | 357 | 2% | 0% | 6 |
10 | ONCOLOGY RESEARCH | 339 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR DECOY | 1060417 | 6% | 54% | 19 | Search TRANSCRIPTION+FACTOR+DECOY | Search TRANSCRIPTION+FACTOR+DECOY |
2 | DECOY | 914188 | 11% | 26% | 34 | Search DECOY | Search DECOY |
3 | NF KAPPA B DECOY | 541108 | 3% | 53% | 10 | Search NF+KAPPA+B+DECOY | Search NF+KAPPA+B+DECOY |
4 | TRANSCRIPTION FACTOR DECOY TFD | 308437 | 1% | 100% | 3 | Search TRANSCRIPTION+FACTOR+DECOY+TFD | Search TRANSCRIPTION+FACTOR+DECOY+TFD |
5 | PNA DNA CHIMERAS | 246742 | 2% | 40% | 6 | Search PNA+DNA+CHIMERAS | Search PNA+DNA+CHIMERAS |
6 | CRYBP1 | 205624 | 1% | 100% | 2 | Search CRYBP1 | Search CRYBP1 |
7 | SYNTHETIC DOUBLE STRANDED OLIGODEOXYNUCLEOTIDE | 205624 | 1% | 100% | 2 | Search SYNTHETIC+DOUBLE+STRANDED+OLIGODEOXYNUCLEOTIDE | Search SYNTHETIC+DOUBLE+STRANDED+OLIGODEOXYNUCLEOTIDE |
8 | DECOY OLIGODEOXYNUCLEOTIDE | 194794 | 2% | 32% | 6 | Search DECOY+OLIGODEOXYNUCLEOTIDE | Search DECOY+OLIGODEOXYNUCLEOTIDE |
9 | DECOY STRATEGY | 185060 | 1% | 60% | 3 | Search DECOY+STRATEGY | Search DECOY+STRATEGY |
10 | CIS ELEMENT DECOY | 182773 | 1% | 44% | 4 | Search CIS+ELEMENT+DECOY | Search CIS+ELEMENT+DECOY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GAMBARI, R , (2004) NEW TRENDS IN THE DEVELOPMENT OF TRANSCRIPTION FACTOR DECOY (TFD) PHARMACOTHERAPY.CURRENT DRUG TARGETS. VOL. 5. ISSUE 5. P. 419-430 | 49 | 34% | 22 |
2 | BORGATTI, M , BEZZERRI, V , NICOLIS, E , LAMPRONTI, I , DECHECCHI, MC , MANCINI, I , TAMANINI, A , CABRINI, G , GAMBARI, R , (2010) DECOY OLIGODEOXYRIBONUCLEOTIDES AND PEPTIDE NUCLEIC ACIDS-DNA CHIMERAS TARGETING NUCLEAR FACTOR KAPPA-B: INHIBITION OF IL-8 GENE EXPRESSION IN CYSTIC FIBROSIS CELLS INFECTED WITH PSEUDOMONAS AERUGINOSA.BIOCHEMICAL PHARMACOLOGY. VOL. 80. ISSUE 12. P. 1887 -1894 | 29 | 36% | 14 |
3 | DE STEFANO, D , (2011) OLIGONUCLEOTIDES DECOY TO NF-KAPPAB: BECOMING A REALITY?.DISCOVERY MEDICINE. VOL. 12. ISSUE 63. P. 97 -105 | 28 | 37% | 9 |
4 | MANN, MJ , (2005) TRANSCRIPTION FACTOR DECOYS - A NEW MODEL FOR DISEASE INTERVENTION.THERAPEUTIC OLIGONUCLEOTIDES: TRANSCRIPTIONAL AND TRANSLATIONAL STRATEGIES FOR SILENCING GENE EXPRESSION. VOL. 1058. ISSUE . P. 128 -139 | 24 | 49% | 15 |
5 | METELEV, VG , KUBAREVA, EA , ORETSKAYA, TS , (2013) REGULATION OF ACTIVITY OF TRANSCRIPTION FACTOR NF-KAPPA B BY SYNTHETIC OLIGONUCLEOTIDES.BIOCHEMISTRY-MOSCOW. VOL. 78. ISSUE 8. P. 867-878 | 26 | 36% | 2 |
6 | MORISHITA, R , TOMITA, N , KANEDA, Y , OGIHARA, T , (2004) MOLECULAR THERAPY TO INHIBIT NF KAPPA B ACTIVATION BY TRANSCRIPTION FACTOR DECOY OLIGONUCLEOTIDES.CURRENT OPINION IN PHARMACOLOGY. VOL. 4. ISSUE 2. P. 139-146 | 19 | 48% | 67 |
7 | PENOLAZZI, L , BORGATTI, M , LAMBERTINI, E , MISCHIAT, C , FINOTTI, A , ROMANELLI, A , SAVIANO, M , PEDONE, C , PIVA, R , GAMBARI, R , (2004) PEPTIDE NUCLEIC ACID-DNA DECOY CHIMERAS TARGETING NF-KAPPA B TRANSCRIPTION FACTORS: INDUCTION OF APOPTOSIS IN HUMAN PRIMARY OSTEOCLASTS.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. VOL. 14. ISSUE 2. P. 145-152 | 22 | 44% | 15 |
8 | OSAKO, MK , NAKAGAMI, H , MORISHITA, R , (2012) DEVELOPMENT AND MODIFICATION OF DECOY OLIGODEOXYNUCLEOTIDES FOR CLINICAL APPLICATION.NUCLEIC ACID DRUGS. VOL. 249. ISSUE . P. 49 -59 | 14 | 56% | 1 |
9 | DE STEFANO, D , DE ROSA, G , CARNUCCIO, R , (2010) NF KAPPA B DECOY OLIGONUCLEOTIDES.CURRENT OPINION IN MOLECULAR THERAPEUTICS. VOL. 12. ISSUE 2. P. 203 -213 | 32 | 24% | 13 |
10 | BENE, A , KURTEN, RC , CHAMBERS, TC , (2004) SUBCELLULAR LOCALIZATION AS A LIMITING FACTOR FOR UTILIZATION OF DECOY OLIGONUCLEOTIDES.NUCLEIC ACIDS RESEARCH. VOL. 32. ISSUE 19. P. - | 12 | 67% | 13 |
Classes with closest relation at Level 1 |